Epigenetic histone modification of Epstein-Barr virus BZLF1 promoter during latency and reactivation in Raji cells

Journal of Virology

Volumn 86, Issue 9, 2012, Pages 4752-4761

  Murata, Takayuki ^a   Kondo, Yutaka ^a   Sugimoto, Atsuko ^a   Kawashima, Daisuke ^a   Saito, Shinichi ^a   Isomura, Hiroki ^a   Kanda, Teru ^a   Tsurumi, Tatsuya ^a  

^a AICHI CANCER CENTER HOSPITAL   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

3 DEAZANEPLANOCIN A; HISTONE; HISTONE METHYLTRANSFERASE; IMMEDIATE EARLY PROTEIN BZLF1; LYSINE; SMALL INTERFERING RNA; TRANSCRIPTION FACTOR EZH2; TRICHOSTATIN A;

ARTICLE; BZLF1 GENE; CONTROLLED STUDY; DEACETYLATION; EPSTEIN BARR VIRUS; GENETIC TRANSCRIPTION; HISTONE ACETYLATION; HISTONE METHYLATION; HISTONE MODIFICATION; IMMUNOBLOTTING; NONHUMAN; PRIORITY JOURNAL; PROMOTER REGION; PROTEIN EXPRESSION; RAJI CELL; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; RNA INTERFERENCE; VIRUS GENE; VIRUS LATENCY; VIRUS REACTIVATION;

AZACITIDINE; CELL LINE; DNA MODIFICATION METHYLASES; DNA-BINDING PROTEINS; EPIGENESIS, GENETIC; GENE EXPRESSION REGULATION, VIRAL; GENE SILENCING; HERPESVIRUS 4, HUMAN; HISTONE DEACETYLASE INHIBITORS; HISTONE-LYSINE N-METHYLTRANSFERASE; HISTONES; HUMANS; PROMOTER REGIONS, GENETIC; TRANS-ACTIVATORS; TRANSCRIPTION FACTORS; VIRUS LATENCY;

HUMAN HERPESVIRUS 4;

EID: 84861313347     PISSN: 0022538X     EISSN: 10985514     Source Type: Journal    
DOI: 10.1128/JVI.06768-11     Document Type: Article

References (58)

1. Amon W, Farrell PJ. 2005. Reactivation of Epstein-Barr virus from latency. Rev. Med. Virol. 15:149-156.
2. Bhende PM, Dickerson SJ, Sun X, Feng WH, Kenney SC. 2007. X-boxbinding protein 1 activates lytic Epstein-Barr virus gene expression in combination with protein kinase D. J. Virol. 81:7363-7370.
3. Binne UK, Amon W, Farrell PJ. 2002. Promoter sequences required for reactivation of Epstein-Barr virus from latency. J. Virol. 76:10282-10289.
4. Bloom DC, Giordani NV, Kwiatkowski DL. 2010. Epigenetic regulation of latent HSV-1 gene expression. Biochim. Biophys. Acta 1799:246-256.
5. Cao R, et al. 2002. Role of histone H3 lysine 27 methylation in Polycombgroup silencing. Science 298:1039-1043.
6. Chau CM, Lieberman PM. 2004. Dynamic chromatin boundaries delineate a latency control region of Epstein-Barr virus. J. Virol. 78:12308-12319.
7. Cliffe AR, Garber DA, Knipe DM. 2009. Transcription of the herpes simplex virus latency-associated transcript promotes the formation of facultative heterochromatin on lytic promoters. J. Virol. 83:8182-8190.
8. Cliffe AR, Knipe DM. 2008. Herpes simplex virus ICP0 promotes both histone removal and acetylation on viral DNA during lytic infection. J. Virol. 82:12030-12038.
9. Cohen GH, et al. 1980. Structural analysis of the capsid polypeptides of herpes simplex virus types 1 and 2. J. Virol. 34:521-531.
10. Countryman J, et al. 2009. Stimulus duration and response time independently influence the kinetics of lytic cycle reactivation of Epstein-Barr virus. J. Virol. 83:10694-10709.
11. Countryman JK, Gradoville L, Miller G. 2008. Histone hyperacetylation occurs on promoters of lytic cycle regulatory genes in Epstein-Barr virusinfected cell lines which are refractory to disruption of latency by histone deacetylase inhibitors. J. Virol. 82:4706-4719.
12. Day L, et al. 2007. Chromatin profiling of Epstein-Barr virus latency control region. J. Virol. 81:6389-6401.
13. Delecluse HJ, Bartnizke S, Hammerschmidt W, Bullerdiek J, Bornkamm GW. 1993. Episomal and integrated copies of Epstein-Barr virus coexist in Burkitt lymphoma cell lines. J. Virol. 67:1292-1299.
14. Feng WH, Hong G, Delecluse HJ, Kenney SC. 2004. Lytic induction therapy for Epstein-Barr virus-positive B-cell lymphomas. J. Virol. 78: 1893-1902.
15. Fernandez AF, et al. 2009. The dynamic DNA methylomes of doublestranded DNA viruses associated with human cancer. Genome Res. 19: 438-451.
16. Flemington E, Speck SH. 1990. Autoregulation of Epstein-Barr virus putative lytic switch gene BZLF1. J. Virol. 64:1227-1232.
17. Gradoville L, Kwa D, El-Guindy A, Miller G. 2002. Protein kinase C-independent activation of the Epstein-Barr virus lytic cycle. J. Virol. 76:5612-5626.
18. Gunther T, Grundhoff A. 2010. The epigenetic landscape of latent Kaposi sarcoma-associated herpesvirus genomes. PLoS Pathog. 6:e1000935.
19. Hagemeier SR, et al. 2010. Sumoylation of the Epstein-Barr virus BZLF1 protein inhibits its transcriptional activity and is regulated by the virusencoded protein kinase. J. Virol. 84:4383-4394.
20. Hatfull G, Bankier AT, Barrell BG, Farrell PJ. 1988. Sequence analysis of Raji Epstein-Barr virus DNA. Virology 164:334-340.
21. Huang J, et al. 2006. Trimethylation of histone H3 lysine 4 by Set1 in the lytic infection of human herpes simplex virus 1. J. Virol. 80:5740-5746.
22. Jenkins PJ, Binne UK, Farrell PJ. 2000. Histone acetylation and reactivation of Epstein-Barr virus from latency. J. Virol. 74:710-720.
23. Kalla M, Schmeinck A, Bergbauer M, Pich D, Hammerschmidt W. 2010. AP-1 homolog BZLF1 of Epstein-Barr virus has two essential functions dependent on the epigenetic state of the viral genome. Proc. Natl. Acad. Sci. U. S. A. 107:850-855.
24. Kennedy G, Sugden B. 2003. EBNA-1, a bifunctional transcriptional activator. Mol. Cell. Biol. 23:6901-6908.
25. Kent JR, et al. 2004. During lytic infection herpes simplex virus type 1 is associated with histones bearing modifications that correlate with active transcription. J. Virol. 78:10178-10186.
26. Kim YW, Kim A. 2011. Characterization of histone H3K27 modifications in the beta-globin locus. Biochem. Biophys. Res. Commun. 405:210-215.
27. Knipe DM, Cliffe A. 2008. Chromatin control of herpes simplex virus lytic and latent infection. Nat. Rev. Microbiol. 6:211-221.
28. Kondo Y. 2009. Epigenetic cross-talk between DNA methylation and histone modifications in human cancers. Yonsei Med. J. 50:455-463.
29. Kondo Y, et al. 2008. Gene silencing in cancer by histone H3 lysine 27 trimethylation independent of promoter DNA methylation. Nat. Genet. 40:741-750.
30. Kubicek S, et al. 2007. Reversal of H3K9me2 by a small-molecule inhibitor for the G9a histone methyltransferase. Mol. Cell 25:473-481.
31. Kudoh A, et al. 2003. Reactivation of lytic replication from B cells latently infected with Epstein-Barr virus occurs with high S-phase cyclindependent kinase activity while inhibiting cellular DNA replication. J. Virol. 77:851-861.
32. Kwiatkowski DL, Thompson HW, Bloom DC. 2009. The polycomb group protein Bmi1 binds to the herpes simplex virus 1 latent genome and maintains repressive histone marks during latency. J. Virol. 83:8173-8181.
33. Liu P, Liu S, Speck SH. 1998. Identification of a negative cis element within the ZII domain of the Epstein-Barr virus lytic switch BZLF1 gene promoter. J. Virol. 72:8230-8239.
34. Liu S, Borras AM, Liu P, Suske G, Speck SH. 1997. Binding of the ubiquitous cellular transcription factors Sp1 and Sp3 to the ZI domains in the Epstein-Barr virus lytic switch BZLF1 gene promoter. Virology 228: 11-18.
35. Liu S, Liu P, Borras A, Chatila T, Speck SH. 1997. Cyclosporin A-sensitive induction of the Epstein-Barr virus lytic switch is mediated via a novel pathway involving a MEF2 family member. EMBO J. 16:143-153.
36. Lu X, Triezenberg SJ. 2010. Chromatin assembly on herpes simplex virus genomes during lytic infection. Biochim. Biophys. Acta 1799:217-222.
37. Luka J, Kallin B, Klein G. 1979. Induction of the Epstein-Barr virus (EBV) cycle in latently infected cells by n-butyrate. Virology 94:228-231.
38. Miller G, El-Guindy A, Countryman J, Ye J, Gradoville L. 2007. Lytic cycle switches of oncogenic human gammaherpesviruses. Adv. Cancer Res. 97:81-109.
39. Miranda TB, et al. 2009. DZNep is a global histone methylation inhibitor that reactivates developmental genes not silenced by DNA methylation. Mol. Cancer Ther. 8:1579-1588.
40. Montalvo EA, Cottam M, Hill S, Wang YJ. 1995. YY1 binds to and regulates cis-acting negative elements in the Epstein-Barr virus BZLF1 promoter. J. Virol. 69:4158-4165.
41. Murata T, et al. 2010. Transcriptional repression by sumoylation of Epstein-Barr virus BZLF1 protein correlates with association of histone deacetylase. J. Biol. Chem. 285:23925-23935.
42. Murata T, et al. 2011. Involvement of Jun dimerization protein 2 (JDP2) in the maintenance of Epstein-Barr virus latency. J. Biol. Chem. 286: 22007-22016.
43. Murata T, et al. 2009. TORC2, a coactivator of cAMP-response elementbinding protein, promotes Epstein-Barr virus reactivation from latency through interaction with viral BZLF1 protein. J. Biol. Chem. 284:8033-8041.
44. Nagata H, et al. 2001. Characterization of novel natural killer (NK)-cell and gammadelta T-cell lines established from primary lesions of nasal T/NK-cell lymphomas associated with the Epstein-Barr virus. Blood 97: 708-713.
45. Narayanan A, Ruyechan WT, Kristie TM. 2007. The coactivator host cell factor-1 mediates Set1 and MLL1 H3K4 trimethylation at herpesvirus immediate early promoters for initiation of infection. Proc. Natl. Acad. Sci. U. S. A. 104:10835-10840.
46. Oh J, Fraser NW. 2008. Temporal association of the herpes simplex virus genome with histone proteins during a lytic infection. J. Virol. 82:3530-3537.
47. Ramasubramanyan S, Osborn K, Flower K, Sinclair AJ. 2012. Dynamic chromatin environment of key lytic cycle regulatory regions of the Epstein-Barr virus genome. J. Virol. 86:1809-1819.
48. Ruf IK, Rawlins DR. 1995. Identification and characterization of ZIIBC, a complex formed by cellular factors and the ZII site of the Epstein-Barr virus BZLF1 promoter. J. Virol. 69:7648-7657.
49. Schotta G, et al. 2004. A silencing pathway to induce H3-K9 and H4-K20 trimethylation at constitutive heterochromatin. Genes Dev. 18:1251-1262.
50. Speck SH, Chatila T, Flemington E. 1997. Reactivation of Epstein-Barr virus: regulation and function of the BZLF1 gene. Trends Microbiol. 5:399-405.
51. Tan J, et al. 2007. Pharmacologic disruption of Polycomb-repressive complex 2-mediated gene repression selectively induces apoptosis in cancer cells. Genes Dev. 21:1050-1063.
52. Toth Z, et al. 2010. Epigenetic analysis of KSHV latent and lytic genomes. PLoS Pathog. 6:e1001013.
53. Tsurumi T, Fujita M, Kudoh A. 2005. Latent and lytic Epstein-Barr virus replication strategies. Rev. Med. Virol. 15:3-15.
54. Wang QY, et al. 2005. Herpesviral latency-associated transcript gene promotes assembly of heterochromatin on viral lytic-gene promoters in latent infection. Proc. Natl. Acad. Sci. U. S. A. 102:16055-16059.
55. Wen W, et al. 2007. Epstein-Barr virus BZLF1 gene, a switch from latency to lytic infection, is expressed as an immediate-early gene after primary infection of B lymphocytes. J. Virol. 81:1037-1042.
56. Yamamoto N, Bister K, zur Hausen H. 1979. Retinoic acid inhibition of Epstein-Barr virus induction. Nature 278:553-554.
57. Ye J, Gradoville L, Daigle D, Miller G. 2007. De novo protein synthesis is required for lytic cycle reactivation of Epstein-Barr virus, but not Kaposi's sarcoma-associated herpesvirus, in response to histone deacetylase inhibitors and protein kinase C agonists. J. Virol. 81:9279-9291.
58. Yu X, Wang Z, Mertz JE. 2007. ZEB1 regulates the latent-lytic switch in infection by Epstein-Barr virus. PLoS Pathog. 3:e194.